Switchable Voltage Electrochemical Sensor for Interfering Species Rejection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Implantable biosensors face interference from electroactive compounds like acetaminophen and ascorbic acid, leading to erroneous glucose readings in diabetic patients, as these compounds can directly contribute to the electrode current, reducing sensor accuracy and increasing the risk of insulin overdose.
Innovation Solution
A three-electrode all-platinum sensor setup with a platinum working electrode, counter electrode, and platinum reference electrode, coated with an oxidase enzyme, operates at lower voltages to selectively reject interfering species while maintaining sensitivity to the molecule of interest, allowing for accurate glucose concentration measurement by comparing current-voltage curves with and without interfering species.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional electrochemical sensors operate at conventional voltages to detect glucose, then sensitivity to glucose is maintained, but interfering species like acetaminophen and ascorbic acid directly contribute to electrode current, causing erroneous readings
Solution Approach 1:
The patent applies parameter changes by operating the sensor at lowered voltages (e.g., 0.0-0.3 V vs. Ag/AgCl) compared to conventional voltages. This voltage modification selectively reduces the contribution of interfering electroactive compounds to the electrode current while preserving glucose detection capability through the enzyme-based mechanism, thereby resolving the interference problem without sacrificing measurement precision
2Object-affected harmful factors
If additional blocking layers are added to reject interfering species, then interference is reduced, but device complexity increases and manufacturing becomes more difficult
Solution Approach 1:
The patent extracts the interference rejection function from physical blocking layers and implements it through voltage-based selective detection. By removing the need for additional blocking layers and using electrochemical parameter modification (voltage control), the solution reduces device complexity while maintaining the ability to reject interfering species
Solution Approach 2:
The patent replaces mechanical blocking layers with an electrochemical solution approach. Instead of using physical barriers to block interfering compounds, the system uses voltage-controlled electrochemical selectivity to achieve interference rejection, substituting a mechanical structure with an electrical/control-based mechanism
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The platinum-based sensor effectively reduces errors due to interfering species by 15-30% at normal glucose levels and less than 5% at high physiological levels of acetaminophen and ascorbic acid, enhancing the accuracy and reliability of glucose monitoring without the need for additional blocking layers.
Implementation Method 1
an enzyme layer covering the working electrode
Implementation Method 2
coated with an oxidase enzyme
Implementation Method 3
a working electrode, made of Pt, on the substrate
Data Source
AI summary
A sensor implanted in tissues and including a sensing enzyme takes an electrical measurement and compares it to reference curves for the voltage current relationship. The sensor determines whether molecular compounds are present which interfere with the detection of the molecule of interest. If interfering species are found, the measurement voltage is set in a low range to reduce errors, while if the interfering species are not found, the measurement voltage is set in a high range to increase the detected signal.